Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3039% above fair value
$610.54−23.44 (-3.70%)
Close on Nov 20, 2026Market cap $17.08BP/E 33.9Yield –
Medpace shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Medpace's shares outstanding was 28M at Sep 30, 2026. For fiscal 2025 it was 30M, down 7.8% from the year before. Over ten years it grew -0.6% a year on average. The highest annual figure on record is 40M in fiscal 2017.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30M | -7.8% |
| FY2024 | Dec 31, 2024 | 32M | +0.5% |
| FY2023 | Dec 31, 2023 | 32M | -5.4% |
| FY2022 | Dec 31, 2022 | 34M | -10.7% |
| FY2021 | Dec 31, 2021 | 38M | -0.0% |
| FY2020 | Dec 31, 2020 | 38M | +0.4% |
| FY2019 | Dec 31, 2019 | 38M | +1.8% |
| FY2018 | Dec 31, 2018 | 37M | -7.3% |
| FY2017 | Dec 31, 2017 | 40M | +9.7% |
| FY2016 | Dec 31, 2016 | 36M | +15.9% |
| FY2015 | Dec 31, 2015 | 31M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 28M | -1.5% |
| Q2 FY2026 | Jun 30, 2026 | 29M | -2.0% |
| Q1 FY2026 | Mar 31, 2026 | 29M | -7.2% |
| Q4 FY2025 | Dec 31, 2025 | 29M | -9.1% |
| Q3 FY2025 | Sep 30, 2025 | 29M | -10.2% |
| Q2 FY2025 | Jun 30, 2025 | 29M | -9.2% |
| Q1 FY2025 | Mar 31, 2025 | 31M | -2.5% |
| Q4 FY2024 | Dec 31, 2024 | 32M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | 32M | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | 32M | +1.6% |
| Q1 FY2024 | Mar 31, 2024 | 32M | -0.5% |
| Q4 FY2023 | Dec 31, 2023 | 32M | -1.7% |
| Q3 FY2023 | Sep 30, 2023 | 32M | -1.5% |
| Q2 FY2023 | Jun 30, 2023 | 32M | -6.3% |
| Q1 FY2023 | Mar 31, 2023 | 32M | -11.6% |
| Q4 FY2022 | Dec 31, 2022 | 32M | -14.5% |
| Q3 FY2022 | Sep 30, 2022 | 32M | -14.0% |
| Q2 FY2022 | Jun 30, 2022 | 34M | -10.7% |
| Q1 FY2022 | Mar 31, 2022 | 36M | -3.7% |
| Q4 FY2021 | Dec 31, 2021 | 38M | +0.5% |
| Q3 FY2021 | Sep 30, 2021 | 38M | -0.6% |
| Q2 FY2021 | Jun 30, 2021 | 38M | +1.0% |
| Q1 FY2021 | Mar 31, 2021 | 38M | -0.7% |
| Q4 FY2020 | Dec 31, 2020 | 38M | -0.3% |
| Q3 FY2020 | Sep 30, 2020 | 38M | -0.2% |
| Q2 FY2020 | Jun 30, 2020 | 37M | -0.2% |
| Q1 FY2020 | Mar 31, 2020 | 38M | +2.0% |
| Q4 FY2019 | Dec 31, 2019 | 38M | +1.4% |
| Q3 FY2019 | Sep 30, 2019 | 38M | +1.9% |
| Q2 FY2019 | Jun 30, 2019 | 37M | +2.0% |
| Q1 FY2019 | Mar 31, 2019 | 37M | +2.3% |
| Q4 FY2018 | Dec 31, 2018 | 37M | -1.3% |
| Q3 FY2018 | Sep 30, 2018 | 37M | -5.6% |
| Q2 FY2018 | Jun 30, 2018 | 37M | -10.2% |
| Q1 FY2018 | Mar 31, 2018 | 36M | -12.2% |
| Q4 FY2017 | Dec 31, 2017 | 38M | -10.6% |
| Q3 FY2017 | Sep 30, 2017 | 39M | – |
| Q2 FY2017 | Jun 30, 2017 | 41M | – |
| Q1 FY2017 | Mar 31, 2017 | 42M | – |
| Q4 FY2016 | Dec 31, 2016 | 42M | – |
See a number that looks wrong?